Using brain tumor samples collected from children in the United States and Europe, an international team of scientists found that the drug panobinostat and similar gene regulating drugs may be effective at treating diffuse intrinsic pontine gliomas (DIPG), an aggressive and lethal form of pediatric cancer. The study, published in Nature Medicine, was partially funded by the National Institutes of Health, the Department of Defense, and more than 25 nonprofit foundations devoted to finding cures for childhood brain cancer.

Related posts:

  1. Funded study shows reduction in death for men with intermediate-grade prostate cancer Short-term hormone therapy given in combination with radiation therapy to men with early-stage prostate cancer increased their chances of living longer compared to treatment with radiation therapy alone, according to a clinical trial supported by the National Cancer Institute (NCI), part of the National Institutes of Health. Benefits of the combined treatment were limited mainly […]...
  2. Medicare Card, The Most Common Form of Brain Cancer in Adults Medicare Card, The Most Common Form of Brain Cancer in Adults...
  3. Study identifies gene that suppresses cell’s immune activation A new study of prostate tumors has shown that a gene, FOXO3, suppresses activation of cells related to immunity and thus leads to a reduced immune response against a growing cancer. One of the main problems in treating cancer by vaccine or immunotherapy is that tumors often evade the body’s immune response — and one […]...
  4. Medicare Card, Tanning gene linked to increased risk of testicular cancer Medicare Card, Tanning gene linked to increased risk of testicular cancer ...
  5. Medicare Card, Researchers find link between death of tumor-support cells and cancer metastasis Medicare Card, Researchers find link between death of tumor-support cells and cancer metastasis...
  6. Medicare Card, Repurposed experimental cancer drug restores brain function in mouse models of Alzheimer’s disease Scientists have found that a compound originally developed as a cancer therapy potentially could be used to treat Alzheimer’s disease. The team demonstrated that the drug, saracatinib, restores memory loss and reverses brain problems in mouse models of Alzheimer’s, and now the researchers are testing saracatinib’s effectiveness in humans. The study was funded by the […]...
  7. Medicare Future? Pathways that Can Repair Brca1 Cancer Gene Mutation Clarified in Mice In a new study in mice, scientists have compensated for mutations in the Brca1 gene that can lead to cancer by deleting a second gene, which then lessens the probability of cancer. Mice Brca1-associated mammary tumors have significant similarities to human BRCA1- associated (BReast CAncer 1, early onset) breast cancer in regard to tumor aggressiveness, high incidence, mutations and genetic instability. The study, led by scientists at National Cancer Institute (NCI), part of the National Institutes of Health, and their colleagues, appeared online April 1, 2010 and in print April 16, 2010, in the journal Cell....
  8. Adding Psychotherapy to Medication Treatment Improves Outcomes in Pediatric OCD Youth with obsessive compulsive disorder (OCD) who are already taking antidepressant medication benefit by adding a type of psychotherapy called cognitive behavior therapy (CBT), according to an NIMH-funded study published September 21, 2011, in the Journal of the American Medical Association....
  9. Medicare Card, NIH study suggests gene variation may shape bladder cancer treatment Medicare Card, NIH study suggests gene variation may shape bladder cancer treatment...
  10. Medicare Card, NIH study links Hodgkin lymphoma treatment to possible risk of stomach cancer Medicare Card, NIH study links Hodgkin lymphoma treatment to possible risk of stomach cancer...
  11. Medicare Card, NIH mouse study finds gut microorganisms may determine cancer treatment outcome An unhealthy gut microbiome may limit treatment effectiveness.  An intact population of microorganisms that derive food and benefit from other organisms living in the intestine is required for optimal response to cancer therapy, according to a mouse study by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health, and their […]...
  12. Medicare Card, NIH-funded study points way forward for retinal disease gene therapy Medicare Card, NIH-funded study points way forward for retinal disease gene therapy...
  13. Medicare Card, Unexpected protein partnership has implications for cancer treatment NIH scientists find unusual method that may alter tumor growth.  Scientists have identified two unlikely partners in a type of immune cell called a macrophage that work together in response to cancer drugs to increase inflammation in a way that may alter tumor growth. Researchers from the National Institutes of Health published the study in […]...
  14. Medicare Card, Social interaction affects cancer patients’ response to treatment Medicare Card, Social interaction affects cancer patients’ response to treatment...
  15. Medicare, Funded HIV clinical research sites to join pediatric tuberculosis vaccine study Several U.S. government-funded HIV/AIDS clinical research sites in Africa will join other collaborators in an ongoing clinical trial testing an investigational tuberculosis (TB) vaccine in infants at risk for TB infection. “We are pleased to be able to tap into our existing HIV/AIDS clinical research infrastructure to help test promising investigational vaccines against TB,” said […]...